KeyBank National Association
ARGS

KeyBank National Association’s Argos Therapeutics, Inc. ARGS Stock Holding History

KeyBank National Association’s Portfolio ARGS Stock Details ARGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-5,976
Closed -$18K – 1113
2017
Q4 		$18K Hold
5,976
– – ﹤0.01% 1046
2017
Q3 		$22K Buy
+5,976
New +$28.7K ﹤0.01% 1099
2017
Q1 		– Sell
-1,218
Closed -$119K – 1191
2016
Q4 		$119K Hold
1,218
– – ﹤0.01% 1119
2016
Q3 		$121K Hold
1,218
– – ﹤0.01% 1124
2016
Q2 		$149K Sell
1,218
-559
-31% -$74.6K ﹤0.01% 1066
2016
Q1 		$227K Buy
1,777
+594
+50% +$48K ﹤0.01% 1000
2015
Q4 		$55K Hold
1,183
– – ﹤0.01% 1118
2015
Q3 		$114K Hold
1,183
– – ﹤0.01% 1104
2015
Q2 		$162K Hold
1,183
– – ﹤0.01% 1163
2015
Q1 		$211K Buy
1,183
+440
+59% +$76.6K ﹤0.01% 1145
2014
Q4 		$149K Sell
743
-216
-23% -$38.8K ﹤0.01% 1182
2014
Q3 		$193K Sell
959
-384
-29% -$60K ﹤0.01% 1171
2014
Q2 		$216K Buy
1,343
+112
+9% +$18.5K ﹤0.01% 1187
2014
Q1 		$246K Buy
+1,231
New +$246K ﹤0.01% 1148

Other funds holding ARGS

PI
Pharmstandard International Luxembourg $29M AUM 3.25% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 28.91% 1-Year Est. Return
APA
American Portfolios Advisors Holbrook, New York $2.36B AUM 14.59% 1-Year Est. Return

KeyBank National Association's ARGS Position: Q1 2018 in Review

KeyBank National Association sold out of Argos Therapeutics, Inc. (ARGS) in Q1 2018, closing a stake of 5,976 shares — an estimated $18K sold.

KeyBank National Association first reported a position in ARGS in Q1 2014 and held it in 14 quarters. The position peaked at $246K in Q1 2014. 16 funds tracked by Wall St. Rank hold ARGS as of Q1 2018.

  • KeyBank National Association reported no remaining Argos Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • KeyBank National Association sold 5,976 Argos Therapeutics, Inc. shares in Q1 2018, an estimated $18K.
  • KeyBank National Association first reported a position in Argos Therapeutics, Inc. in Q1 2014 and held it in 14 quarters.
  • KeyBank National Association's Argos Therapeutics, Inc. position peaked at $246K in Q1 2014.
  • 16 funds tracked by Wall St. Rank held Argos Therapeutics, Inc. as of Q1 2018.

Based on KeyBank National Association's 13F filing for Q1 2018, filed 15 May 2018.